CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 80 target
Drug / intervention
Constraint-Induced Movement Therapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00059696
NCT00059696Phase 2Completed
CompareCT.gov

A Treatment for Excess Motor Disability in the Aged

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·interventional·Posted May 5, 2003·Updated Sep 26, 2016

In Brief

A Phase 2 clinical trial evaluating Constraint-Induced Movement Therapy for Cerebrovascular Disorders. Completed, enrolled 80 participants across 1 site.

Detailed Summary

After a stroke, many patients are left with an impaired arm. Restricting the use of the good arm may improve the use of the bad arm. In "Constraint-Induced Movement" therapy (CI therapy), the good arm is put in a sling to force increased use of the bad arm. The bad arm is also trained each day for several weeks. This study will evaluate the effectiveness of CI therapy in patients with chronic disability after stroke and whether the rate of recovery is decreased in elderly patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebrovascular Disorders
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 5, 2003
Enrollment StartDec 1, 1999
Primary CompletionNov 1, 2004
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 23.2 years ago

Interventions

Constraint-Induced Movement Therapyprocedure